跳至主要内容
临床试验/NCT04876599
NCT04876599已完成不适用

IN FOCUS: A Multimodal Mind-Body Intervention for Fear of Recurrence Among Cancer Survivors

Massachusetts General Hospital10 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2021年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
64
试验地点
10
主要终点
Acceptability: 5 Item Measure of Enjoyableness, Convenience, Helpfulness, Odds of Future Use, and Overall Satisfaction

研究概览

简要总结

The purpose of this study is to test the feasibility of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (FOR) among cancer survivors.

详细描述

This is a randomized pilot feasibility trial (1:1 intervention versus usual care; a referral to community-based cancer survivor support group) that will use mixed methods (quantitative and qualitative) to evaluate the feasibility, acceptability, and preliminary effects of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (IN FOCUS) among cancer survivors with clinically elevated fear of recurrence (N = approximately 64).

Patient-reported outcomes on psychological and behavioral outcomes will be measured at T0 (baseline), T1 (post-intervention/approximately two months post-baseline), and T2 (three months post-intervention/approximately five months post-baseline). Exit interviews will be conducted after the T1 survey. Participants are expected to be in the study for approximately five months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of non-metastatic, localized, or regional solid or blood malignancy(ies)
  • Completion of primary cancer treatment (i.e., radiation, surgery, chemotherapy) and/or current use of long-term maintenance hormonal or biologic therapy
  • Age ≥18 years
  • Elevated fear of recurrence (FCRI severity score ≥16)
  • MGB/BIDMC Medical Record Number (MRN)

排除标准

  • Self-reported inability to speak and write in English
  • Undertreated serious mental illness as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year
  • Inability to access technology and/or sufficient internet to participate virtual groups sessions

结局指标

主要结局

Acceptability: 5 Item Measure of Enjoyableness, Convenience, Helpfulness, Odds of Future Use, and Overall Satisfaction

时间窗: Baseline to approximately 2 months

As a primary quantitative acceptability outcome, participants will be asked to rate the enjoyableness, convenience, helpfulness, odds of future use, and overall satisfaction (1=very low to 5=very high) of the intervention.

Feasibility: Retention Rate

时间窗: Baseline to approximately 2 months

The primary metric for assessing feasibility will be retention at the initial follow-up assessment (≥70% survey completion). For descriptive purposes, secondary exploratory metrics of feasibility will include reasons for ineligibility, refusal, or dropping out will be measured, as will rates of enrollment, ratio of screened-to-eligible, attendance (e.g., ≥75% of intervention sessions attended), self-reported adherence to relaxation skills practice, and interventionist fidelity. Exit interviews will use open-ended questions to assess the feasibility of attending virtual sessions.

次要结局

  • Resiliency(Baseline, approximately 2 months, approximately 5 months)
  • Fear of Cancer Recurrence(Baseline, approximately 2 months, approximately 5 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Hall

Principal Investigator

Massachusetts General Hospital

研究点 (10)

Loading locations...

相似试验